Tag Archives: U.S. Food and Drug Administration

Woodcock Under Investigation

By George Koroneos | Published: August 12, 2009
Image by Getty Images via Daylife An FDA director has come under fire by a generics firm claiming that the director of the Center for Drug Evaluation and Research favored a competitor in a wanton act of conflict of interest. The Wall Street Journal this morning broke the story that Janet Woodcock is under investigation by [...]
Posted in Strategy | Also tagged , , , , , | Leave a comment

Avastin Gets Green Light for Use in Kidney Cancer

By George Koroneos | Published: August 5, 2009
Image by Getty Images via Daylife Score another win for Genentech and its cancer treatment Avastin (bevacizumab). On Monday, the biotech giant, now owned entirely by Roche, announced that FDA has approved the drug for kidney cancer. Avastin blocks new blood vessels from forming and supplying tumors with the nutrients they need to grow and spread to [...]
Posted in News | Also tagged , , , , , , | Leave a comment

GSK Signs $120M Deal to Market DMab Overseas

By George Koroneos | Published: July 29, 2009
Image via Wikipedia In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval. GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Posted in Deals, News, Technology | Also tagged , , , , , , , , , , | Leave a comment

Hamburg Shifts Boxes at FDA

By Jill Wechsler | Published: July 29, 2009
Image via Wikipedia Typical of new administrations, FDA commissioner Margaret Hamburg is moving around some staff functions and bringing in new faces, but holding off on major reorganizational changes at the agency. There will be a new “food czar”—a deputy commissioner of food—but not a comparable official in charge of drugs, biologics and medical devices. Hamburg [...]
Posted in News | Also tagged , , , , | Leave a comment

Novo Nordisk Launches Branded Twitter Campaign

By George Koroneos | Published: July 14, 2009
Novo Nordisk, last week, officially launched its branded Twitter site “Race with Insulin” to keep patients aware of the day-to-day happenings in the life of indie racer Charlie Kimball. Using the social networking tool, Kimball openly talks about what it’s like to live with Type 1 diabetes and tweets about using Novo Nordisk’s Levemir (insulin detemir) [...]
Posted in E-Media | Also tagged , , , , , , | 2 Comments